Newsmeme!
Discover News you didn't know existed
BEDFORD, Mass.----Resolvyx Pharmaceuticals, Inc., the leading resolvin therapeutics company, today announced that the thirty day review period by the U.S. Food and Drug Administration is now complete for an investigational new drug application , with reference #77,896, supporting the use of RX-10045 for the treatment of ophthalmic diseases.
No tags found at this time. Be the first to tag this news item, learn more.
No related news stories found.
None found at this time.
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |